food and drug administration

Food and Drug Administration, cancer and Recall

FDA Recalls Blood Pressure Drug Over Cancer Risk

The FDA classified the affected batches as a Class II risk, meaning use could cause temporary or reversible health effects—and, in rare cases, more serious consequences, as reported by the AP.

· 1d · on MSN

FDA says drug makers have recalled a blood pressure medicine tainted with a cancer-causing chemical

· 1d

Blood pressure drug recalled over cancer concerns. What it means for Ohioans

· 23h

FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical

The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-cau...

· 17h

FDA recalls blood pressure medication over cancer risk, impacting half a million bottles

· 10h

FDA: Blood Pressure Medication Recall Yet Again For Cancer Concerns

India Today on MSN

First GLP-1 drug approved to protect against heart attacks, stroke

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes patients. The drug can be prescribed to reduce major adverse cardiovascular issues even in patients who have not yet experienced these events.

Watch live: RFK Jr., FDA chief give remarks on lowering drug prices

Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary will give remarks on the Trump administration’s push to lower drug

1don MSN

FDA announces plans to relax rules about copycat drugs

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some high-priced medications to reduce costs.

1don MSN

US FDA warns four firms over unapproved fluoride drugs for children

Food and Drug Administration has warned four companies that it plans to take enforcement action over their sale of unapproved fluoride-based prescription drugs for children, the agency said on Friday.

FDA to Speed Biosimilar Approvals in Push to Cut Drug Costs (1)

The FDA is planning to speed approvals of highly similar copies of expensive biologic drugs, the latest effort in President Donald Trump’s aggressive agenda to lower costs for medicines in the US.

Trump Administration Eases Approval Process for Biosimilar Drugs

The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive for drugmakers to develop biosimilar medicines, the copycat versions of off-patent biologic drugs.

16hon MSN

Doctors issue warning about ‘autism drug’ endorsed by Trump administration

More parents are asking with autistic children are asking to prescribe leucovorin despite a lack of data about its benefits

FDA’s New Fast Drug Review Plan Comes With Trade-Offs for Pharma

The FDA’s effort to expedite reviews for drugs in line with the Trump administration’s priorities was greeted warmly by a pharmaceutical industry interested in moving approvals more quickly, but raised concerns about the scope of the plan in light of recent cuts at the agency.

The Manila Times

Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma

CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression Free Survival and Overall Survival